Miocardite após vacinação de adolescentes com BNT162b2 em Israel.
31 Jan, 2022 | 08:55hMyocarditis after BNT162b2 Vaccination in Israeli Adolescents – New England Journal of Medicine
Conteúdos relacionados:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Comentário no Twitter
Data from the Israeli MOH show estimates of myocarditis risk in the 21 days after a first & second dose of vaccine were 0.56 per 100,000 and 8.09 per 100,000 among male recipients and 0 per 100,000 and 0.69 per 100,000 among females. https://t.co/M6kxVA2toS pic.twitter.com/bQ4TBmcrj4
— NEJM (@NEJM) January 29, 2022